1A

After paragraph (1) insert—

1A

The licensing authority may accept an application meeting reduced or alternative requirements specified in this Part (“under the unfettered access route”) and grant a COR(GB) only where—

a

there is already in place, or will be at the time the COR(GB) is granted, a certificate of registration in respect of the product authorising sale or supply in Northern Ireland,

b

the applicant complies with the requirements in paragraph (5B), and

c

the registrable homoeopathic medicinal product satisfies the definition of qualifying Northern Ireland goods.

1B

A certificate of registration must state whether it is in force in—

a

the whole United Kingdom;

b

Great Britain only; or

c

Northern Ireland only,

and in these Regulations the meaning of a reference to that certificate of registration being “in force” is limited to that territory.

for “must be established in the European Union” substitute—

, where it is applying for—

a

a COR(NI)—

i

in accordance with Chapter 4 of Title III of the 2001 Directive, must be established in the European Union;

ii

on any other basis, must be established in the United Kingdom;

b

a COR(GB)—

i

under the unfettered access route, must be established in Northern Ireland;

ii

other than under the unfettered access route, must be established in the United Kingdom;

c

a COR(UK), must be established in the United Kingdom.

2A

After paragraph (5) insert—

5A

The application must include a statement indicating whether the certificate sought is for sale or supply of the product in—

a

the whole United Kingdom;

b

Great Britain only; or

c

Northern Ireland only.

5B

The applicant for the grant of a COR(GB) under the unfettered access route must provide—

a

the application form submitted in connection with the granting of the COR(NI) which authorises the sale or supply of the product in Northern Ireland;

b

a copy of all material submitted in support of the application for the COR(NI) which authorises the sale or supply of the product in Northern Ireland; and

c

a copy of the COR(NI) which authorises the sale or supply of the medicinal product in Northern Ireland,

together with any material specified in paragraph (8) which is not included in the material specified in sub-paragraphs (a) to (c) in relation to the product.